Is there any rule for antiviral therapy in HBV-related compensated cirrhosis patients with serum HBV DNA undetectable or at low levels and normal ALT?

被引:0
|
作者
Yan, Taotao [1 ]
Sha, Xiaoying [3 ]
Wang, Jing [1 ]
Jin, Li [1 ]
Zhang, Yu [2 ]
Yi, Ruitian [1 ]
Cao, Furong [1 ]
Yang, Yuan [2 ]
Liu, Jinfeng [2 ]
He, Yingli [2 ]
Chen, Tianyan [2 ]
Zhao, Yingren [2 ]
机构
[1] Xi An Jiao Tong Univ, Xian 710049, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian 710049, Peoples R China
[3] Eighth Hosp Xian, Dept Infect Dis, Xian, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1541
引用
收藏
页码:961A / 962A
页数:3
相关论文
共 50 条
  • [41] Consistently low hepatitis B virus-DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis
    Ikeda, K
    Kobayashi, M
    Arase, Y
    Someya, T
    Saitoh, S
    Suzuki, Y
    Suzuki, F
    Tsubota, A
    Akuta, N
    Kumada, H
    JOURNAL OF HEPATOLOGY, 2002, 36 : 169 - 169
  • [42] Sequence analysis of serum hepatitis B virus (HBV) RNA represents a novel method for HBV genome analysis of HBV variants in patients achieving undetectable HBV DNA during antiviral treatment
    van Boemmel, Florian
    Schmalbrock, Laura
    Deichsel, Danilo
    Schott, Eckart
    Berg, Thomas
    Boehm, Stephan
    HEPATOLOGY, 2013, 58 : 708A - 708A
  • [43] DO SERUM ALT AND QUANTITATIVE HBV DNA LEVELS PREDICT HISTOLOGIC ACTIVITY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS?: ANALYSIS IN EXPLANTED LIVER
    Kim, Jin Dong
    Choi, Jong Young
    Kwon, Jung Hyun
    You, Chan Ran
    Bae, Si Hyun
    Yoon, Seung Kew
    Cho, Se Hyun
    Yang, Jin Mo
    Han, Joon-Yeol
    Han, Nam Ik
    Choi, Sang Wook
    Lee, Young Sok
    Lee, Chang Don
    Jung, Eun Sun
    HEPATOLOGY, 2008, 48 (04) : 744A - 744A
  • [44] Cost-effectiveness analysis of HBV-related hepatocellular carcinoma screening in cirrhosis patients with antiviral treatment in China
    Zhang, Meng
    Li, Yaoguang
    Zhang, Shunxiang
    Zhang, Jianying
    CANCER RESEARCH, 2020, 80 (16)
  • [45] Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA
    Zhou, Jing
    Wang, Fada
    Li, Lanqing
    Chen, Enqiang
    PRECISION CLINICAL MEDICINE, 2022, 5 (04)
  • [46] HEALTH RELATED QUALITY OF LIFE (HRQoL) IN COMPENSATED HBV-INDUCED LIVER CIRRHOSIS PATIENTS SIGNIFICANTLY IMPROVED AFTER ANTIVIRAL THERAPY
    Hong, Jia
    Wu, Xiaoning
    Zhou, Jialing
    Meng, Tongtong
    Guan, Qiushuang
    Piao, Hongxin
    Feng, Bo
    Jiang, Wei
    Lu, Lungen
    Chen, Yongpeng
    Xie, Wen
    Xu, Youqing
    Huo, Lijuan
    Zhang, Xuqing
    Shang, Jia
    Ma, Anlin
    Cheng, Jilin
    Han, Tao
    Zou, Zhiqiang
    Duan, Weijia
    Wu, Shanshan
    Kong, Yuanyuan
    Ou, Xiaojuan
    Jia, Jidong
    You, Hong
    HEPATOLOGY, 2019, 70 : 448A - 448A
  • [47] Correlation of HBV DNA levels in serum and liver of chronic hepatitis B patients with cirrhosis
    Lee, CZ
    Huang, GT
    Yang, PM
    Sheu, JC
    Lai, MY
    Chen, DS
    LIVER, 2002, 22 (02): : 130 - 135
  • [48] Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: A ten-year retrospective cohort study
    Liu, Jian
    Bai, Shilei
    Shi, Xintong
    Yuan, Tao
    Yu, Yongjin
    Lin, Jianbo
    Dai, Chun
    Wu, Yeye
    Cui, Longjiu
    Zhu, Bin
    Fu, Xiaohui
    Wang, Kui
    Yu, Wenlong
    Li, Jun
    EJSO, 2025, 51 (05):
  • [49] Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
    Lee, I-Cheng
    Lee, Pei-Chang
    Chao, Yee
    Chi, Chen-Ta
    Wu, Chi-Jung
    Hung, Yi-Ping
    Su, Chien-Wei
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    VIRUSES-BASEL, 2022, 14 (11):
  • [50] Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
    Chen, Jian-Lin
    Lin, Xiao-Jun
    Zhou, Qian
    Shi, Ming
    Li, Sheng-Ping
    Lao, Xiang-Ming
    CHINESE JOURNAL OF CANCER, 2016, 35